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Abstract
A low-cost, robust, and simple mechanism to measure hemoglobin would play a
critical role in the modern health infrastructure. Consistent sample acquisition has
been a long-standing technical hurdle for photometer-based portable hemoglobin
detectors which rely on micro cuvettes and dry chemistry. Any particulates (e.g.
intact red blood cells (RBCs), microbubbles, etc.) in a cuvette’s sensing area
drastically impact optical absorption profile, and commercial hemoglobinometers
lack the ability to automatically detect faulty samples. We present the ground-up
development of a portable, low-cost and open platform with equivalent accuracy to
medical-grade devices, with the addition of CNN-based image processing for rapid
sample viability prechecks. The developed platform has demonstrated precision to
the nearest 0.18[g/dL] of hemoglobin, an R2 = 0.945 correlation to hemoglobin
absorption curves reported in literature, and a 97% detection accuracy of poorly-
prepared samples. We see the developed hemoglobin device/ML platform having
massive implications in rural medicine, and consider it an excellent springboard
for robust deep learning optical spectroscopy: a currently untapped source of data
for detection of countless analytes.
1 Introduction
Hemoglobin is one of the most common blood tests requested by clinics, and can be used in
conjunction with other metrics to diagnose a host of diseases and conditions [1][7], quantify the
effects of pharmaceutical drugs [2], and provide a holistic health benchmark [7]. As roughly a quarter
of the world’s population suffers from a form of hemoglobin deficiency [4], there are many niches
where accessible hemoglobin measurement would fulfill significant unmet need [5][6][7].
The widely-adopted approach to point-of-care hemoglobin measurement involves hemolysing whole
blood and converting hemoglobin derivatives for single-wavelength absorption measurement, fol-
lowed by a simple Beer Law calculation [8][9][11]. In present hemoglobin monitors the single
biggest risk of inaccurate counting and as a result, incorrect clinical decision making, is incomplete
hemolysis due to variable reagent performance. Consequently, light scattering interference from
intact cells (lipid membranes) have a drastic effect on spectrophotometric output [15].
Our intention in developing the presented device platform was twofold: to create an effective and
inexpensive hemoglobin solution without the need for hazardous dry reagents such as cyanide
(Drabkin’s method) or sodium azide [8][9][10], and to demonstrate the efficacy of convolutional
neural network based validation for elimination of a long-standing error source in hemoglobin
measurement.
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2 Detection platform summary
The current version of the device has demonstrated: 1) precision to the nearest 0.18[g/dL] of Hb,
2) stability of measurement over time, with no fluctuation from a single sample over 10 minutes
of continuous output, and 3) R2 = 0.945 correlation to optical transmission-Hb curve reported in
literature (Fig.2 image A).
2.1 Device platform
Figure 1: Image A) Design concept rendering. Image B) Completed device with blank strip and
power adapter inserted.
2.1.1 Sensor configuration
For Hb measurement, a paired 540[nm] emitter-detector setup is used for sample transmission
calculation. The LED and photodiode were selected to maximize light emission, photocurrent, and
Hb absorption.
Image pre-processing for sample viability assurance are captured with a Pi Camera attached to a
low-cost optical microscopy setup (separate from device at this point in development). See figure 4
for optical microscopy imaging examples. Both setups have a test strip insertion slot and a plane for
allowing optical analysis.
2.1.2 Signal processing
AnLTC1050 Chopper-stabilized op amp is used in a standard transimpedance amplifier configuration
for signal processing with a reverse-biased photodiode for signal linearity. Additional components
protect sensitive analog signals from various forms of electromagnetic interference, including high
frequency noise and LC-tank oscillation due to inherent component properties. As absorption is taken
at steady-state, signal bandwidth is not a design concern.
Hb concentration is linearly proportional to optical absorbance (A), which is calculated from the
negative log of fractional transmission, Tf/T i. From Beer’s Law:
C = −Klog(Tf
T i
) (1)
for K = 1/(el), where e is the molar extinction coefficient of hemoglobin, l is the transmission path
length (100[µm]), and C is the concentration of hemoglobin in the sample (in [g/dL]).
The device’s microcontroller contains a 10-bit ADC with a minimum voltage increment of 5[mV ].
With a swing of 1.5[V ] the resolution (i.e. the smallest detectable change in sample percent transmis-
sion) is 0.333%. Readjusting R1 to maximize full output swing (5[V ]) will improve resolution in the
next device iteration to 0.1[%T]. For clinically relevant Hb levels and 0.333[%T] increment size, the
resolution is 0.18[g/dL] Hb (i.e. the difference between consecutive Hb values over a 0.333[%T]
step). This exceeds the precision of predicate devices such as Hemocue, which has an overall bias ±
stdev of -0.1± 1.6[g/dL] compared to lab-grade hematology analyzers [3]. Of course, this level of
precision from the presented device assumes no variability in capillary strip performance: a hefty
assumption.
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Figure 2: Image A) Plot of literature-reported Hb values for observed %T measurements (extrapolated
from 540[nm] molar extinction coefficient [12][13][14]) vs. the developed device readout for those
%T values. Strong correlation demonstrates hardware precision and accuracy over the full clinically-
relevant range of hemoglobin levels. Image B) PIN photodiode and first amplifier stage used for
signal acquisition.
2.2 Capillary test strip
The test strip consists of a 100uM microchannel coated with sodium lauryl sulfate (SLS), a non-
toxic surfactant which serves the dual purpose of lysing RBCs to eliminate turbidity and converting
hemoglobin derivatives into a color-stable complex, SLS-Hb.
Figure 3: Image A is a diagram of the capillary strip design used. Strip with blood sample shown in
B. Close-up of a channel demonstrating common issues with dry-reagent capillary strip methods in
image C: turbidity at the bottom of the channel due to intact RBCs and air bubbles (white specks)
at top. Image D shows the mechanical frame of the sensor input slot with the sample transmission
measurement window.
In standard practice with SLS, 20[uL] of whole blood is added and mixed with 5[mL] of
2.08[mmol/L] SLS solution for a 0.52 moles SLS to blood sample volume ratio [11]. To adapt for
dry-chemistry, 17[µmols] of SLS in aqueous solution were deposited and spread evenly onto each
coverslip, for a total of 34[µmols] per 66[µL] available sample volume, maintaining the ratio.
However, since all fluid entering a capillary strip generally shares the same path, depending on
viscosity and RBC density, the first units of blood entering the channel may use up reagent at the
entrance, leaving none for subsequent units (hence incomplete hemolysis). This issue poses a critical
error-source common to all dry capillary strip detection methods, which can be minimized through
clever strip design.
A funnel-shaped channel (Fig.3 image A) was used to help mitigate the “use up” issue described.
Blood deposited at the entrance of the funnel spreads out to cover a larger area before entering the
narrow measurement area, having been hemolyzed by reagent in the funnel. While this design was
generally effective in eliminating turbidity in the measurement window (Fig.3 panel D), variation in
RBC density and sample viscosity prevented proper mixing/reaction on occasion, precluding this
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dry-chemistry approach from large-scale, frequent use with minimal user training. Only an automated
viability check to auto detect such errors when present can completely eliminate this risk.
2.2.1 CNN-based image processing for sample viability check
A core component of the presented system is the trained machine learning model for sample validation.
A separate imaging module was developed to analyze intact cells, air bubbles, and ensure appropriate
sample prep. A filled strip is inserted into the imaging module, several images are taken across the
strip at a scaled magnification, and a trained convolutional neural network determines the viability
of the testing strip. The model was adapted from LeNet structure, and trained on 200 human
Figure 4: Images A,B,D) Image captures from the optical microscopy setup identified by the model
as inadequate for spectrophotometry. Sample A shows debris and color instability. Sample B has
image blur and particulates. Sample D contains intact cells which act as light scatterers. Additionally,
green boxes identify white blood cells from the sample, demonstrating expandability of model for
a vast number of use cases. Image C) Clear view with color stability and no scatterers: ideal for
photometric hemoglobin measurement. Data was collected using a labeling interface of all run test
strips (bottom of E). 200 strip images were labeled by a human identifying sections of debris and cell
boundaries, and the overall image labeled "good" vs. "bad".
labeled images of good/bad test strips. The images were augmented to expand the training set by
8x (rotational, translational, brightness, and hue transformations). These results were then cross
validated on a test set of 100 strip images.
The binary classification model performed with 97% accuracy on the task across the non-augmented
test set - this included filled strips by clinicians and general users. Similarly, cell segmentation
modules were developed to threshold cell boundaries with each candidate cell being trained in a
separate Convolutional Neural Net for type classification (White Blood Cell, Red Blood Cell, etc.).
3 Conclusion
Our platform builds off decades of hemoglobin spectroscopy research, while providing unprecedented
error detection and reliability thanks to convolutional neural networks. We believe this deep learning
approach to on-board quality control can be rapidly scaled to other applications, boosting clinical
performance, end diagnoses, and patient safety.
Given the low-cost, open microcontroller nature of the presented device, we see the platform and
model as a powerful combination for deploying in decentralized or rural areas. Untrained test
operators have been a major reason point-of-care, self-administered hematology tests have remained
unfeasible. However, with robust error correction, the risk of misdiagnosis is greatly reduced and this
radical model of personalized medicine is brought within the realm of possibility.
With high-precision analog sensing and CNN based image processing, we have developed the
foundation for multi-wavelength spectrophotometry, enabling both structural and molecular sample
analyses. We are convinced that the confluence of these distinct, rich sources of data with the speed
and versatility of AI will present numerous opportunities to advance the future of healthcare.
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